These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 600825)

  • 1. [Effect of 1-alpha-hydroxyvitamin D-3 on calcium concentration and the level of immunoreactive parathormone in the serum of patients with chronic renal failure].
    Pietrek J; Kokot F; Kuska J
    Pol Arch Med Wewn; 1977 Nov; 58(5):471-9. PubMed ID: 600825
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin in chronic renal failure.
    Franck H; Keck E; Issa S; Krüskemper HL; von Lilienfeld-Toal H
    Exp Clin Endocrinol; 1988 May; 91(2):202-6. PubMed ID: 3409970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo effect of 1 alpha-hydroxyvitamin D3 on interleukin-2 production in hemodialysis patients.
    Tabata T; Shoji T; Kikunami K; Matsushita Y; Inoue T; Tanaka S; Hino M; Miki T; Nishizawa Y; Morii H
    Nephron; 1988; 50(4):295-8. PubMed ID: 3266311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 1,25-dihydroxycholecalciferol on serum calcium, phosphate, and immunoreactive parathyroid hormone in dogs.
    Oldham SB; Smith R; Hartenbower DL; Henry HL
    Adv Exp Med Biol; 1978; 103():509-16. PubMed ID: 717120
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study of serum ionized calcium and immunoreactive parathyroid hormone in patients with renal disorders].
    Chen HJ; Lai YH; Su YH; Tsai JH
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1985 Mar; 1(3):188-94. PubMed ID: 3871031
    [No Abstract]   [Full Text] [Related]  

  • 6. The acute effects of 1,25-dihydroxycholecalciferol on serum immunoreactive parathyroid hormone in the dog.
    Oldham SB; Smith R; Hartenbower DL; Henry HL; Norman AW; Coburn JW
    Endocrinology; 1979 Jan; 104(1):248-54. PubMed ID: 446351
    [No Abstract]   [Full Text] [Related]  

  • 7. Parathormone activity and rate of progression of chronic renal failure in patients on low-protein diet.
    Aparicio M; Gin H; Merville P; Combe C; de Precigout V; Lafage MH; Bouchet JL; Potaux L
    Nephron; 1990; 56(3):333-4. PubMed ID: 2077420
    [No Abstract]   [Full Text] [Related]  

  • 8. Decrease in serum immunoreactive parathyroid hormone in rats and in parathyroid hormone secretion in vitro by 1,25-dihydroxycholecalciferol.
    Chertow BS; Baylink DJ; Wergedal JE; Su MH; Norman AW
    J Clin Invest; 1975 Sep; 56(3):668-78. PubMed ID: 1159080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cimetidine on serum immunoreactive parathyroid hormone in primary hyperparathyroidism and in chronic hemodialysis patients.
    Lai YH; Tsai JH; Su YH; Torng JK; Huang TJ
    Taiwan Yi Xue Hui Za Zhi; 1983 Dec; 82(12):1216-22. PubMed ID: 6585468
    [No Abstract]   [Full Text] [Related]  

  • 10. Behavior of calciotropic hormones in psoriasis.
    Rico H; Robledo A; Crabranes JA; Lopez-Bran E; Hernandez ER
    Miner Electrolyte Metab; 1991; 17(1):12-5. PubMed ID: 1770911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum iPTH concentration in chronic renal failure and its relationship to calcium metabolism (author's transl)].
    Asano Y; Kusano E; Marumo F; Torigai S; Kikawada R; Matsubayashi T; Sato S; Hirata S
    Nihon Jinzo Gakkai Shi; 1978 Jul; 20(7):747-57. PubMed ID: 722977
    [No Abstract]   [Full Text] [Related]  

  • 12. Calcium set point progressively worsens in hemodialysis patients despite conventional oral 1-alpha hydroxycholecalciferol supplementation.
    Ali AA; Varghese Z; Moorhead JF; Baillod RA; Sweny P
    Clin Nephrol; 1993 Apr; 39(4):205-9. PubMed ID: 8491050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium and parathyroid disorders in children. Chronic renal failure and treatment with calcitriol.
    Chan JC; DeLuca HR
    JAMA; 1979 Mar; 241(12):1242-4. PubMed ID: 762789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphate excretion in chronic renal failure: evidence for a mechanism other than circulating parathyroid hormone.
    Fotino S
    Clin Nephrol; 1977 Dec; 8(6):499-503. PubMed ID: 598054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood levels of 25-hydroxyvitamin D in nephrotic syndrome. Studies in 26 patients.
    Goldstein DA; Oda Y; Kurokawa K; Massry SG
    Ann Intern Med; 1977 Dec; 87(6):664-7. PubMed ID: 931202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on abnormalities of calcium, vitamin D and bone metabolism in patients on maintenance hemodialysis (author's transl)].
    Kitoh C
    Nihon Jinzo Gakkai Shi; 1979 May; 21(5):503-18. PubMed ID: 529620
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum immunoreactive parathyroid hormone and 25-hydroxyvitamin D in patients with uremic bone diseases.
    Shen F-H ; Baylink DJ; Sherrard DJ; Shen L; Maloney NA; Wergedal JE
    J Clin Endocrinol Metab; 1975 Jun; 40(6):1009-17. PubMed ID: 1133150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intravenous alfacalcidol on lymphocyte phenotyping in hemodialysis patients.
    Huraib S; Tanimu D; Abu-Romeh S; al-Khairy K; Quadri K; al-Ghamdi G; Iqbal A
    Am J Kidney Dis; 1998 Dec; 32(6):1036-40. PubMed ID: 9856521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum 25-hydroxyvitamin D and parathyroid hormone in patients with acute renal failure.
    Pietrek J; Kokot F; Kuska J
    Kidney Int; 1978 Feb; 13(2):178-85. PubMed ID: 713278
    [No Abstract]   [Full Text] [Related]  

  • 20. Calcium and phosphate metabolism in chronic renal failure, with particular reference to the effect of 1 alpha-hydroxyvitamin D3.
    Madsen S
    Acta Med Scand Suppl; 1980; 638():3-120. PubMed ID: 6929650
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.